MediSpend experts recently presented a webinar focused on the ever-evolving life science transparency regulations around the world. They discussed the newly released Connecticut pharmaceutical sales representative disclosure report, along with recent transparency updates in Denmark and India. The presentation concluded with the status of requirements in Italy and the United Kingdom.
Public Act 23-171 was signed […]
The global compliance landscape is challenging and constantly evolving. Business complexity is increasing, and enforcement risks are intensifying. As a result, we must continuously assess whether we have the tools necessary to proactively identify and manage risks, and ensure these tools engage the entire organization in the compliance process. Understanding our compliance data is becoming […]
May 22, 2024
Revolutionizing Commercial Compliance for Life Sciences:
MediSpend’s Strategic Acquisition of MedCompli
Portsmouth, NH May 22, 2024 — MediSpend, a global technology company providing best-in-class solutions for the life sciences industry, is thrilled to announce its acquisition of MedCompli, a compliance software solutions provider focused on simplifying life science compliance management. This strategic move […]
For pharmaceutical and medical device manufacturers of all sizes, it is important to stay on top of the latest transparency reporting regulations and HCP/O engagement rules. As a leading provider of transparency reporting and paid HCP engagement management solutions, MediSpend also offers our Legislative Watch to help keep you up-to-date on related legislation.
In this webinar, […]
Life science organizations are dedicated to developing and manufacturing transformative products that enhance lives. To accomplish this mission, they routinely contract with healthcare professionals (HCPs) to research, develop, market and train on these products. HCPs contribute invaluable insights, expertise and medical credibility by providing both a theoretical and practical approach to the products and treatments.
However, […]
Life sciences professionals engaged in transparency reporting understand the myriad of challenges in compiling necessary data for reporting. Navigating challenges such as incomplete records, discrepancies among data sources, duplicate, or late data submissions can significantly compromise the accuracy of reporting. Compliance and transparency teams often endure heightened stress and sleepless nights over these common issues, […]
MediSpend’s legal experts recently presented a webinar shedding light on the recent transparency updates within the life science industry. The presentation covered key topics, such as updates to CMS’ Open Payments reporting, various state considerations and the newly issued OIG General Compliance Program Guidance. Notably, the webinar highlighted recent developments in compliance regulations in both Italy and […]
For pharmaceutical and medical device manufacturers of all sizes, it is important to stay on top of the latest transparency reporting regulations and HCP/O engagement rules. As a leading provider of transparency reporting and paid HCP engagement management solutions, MediSpend also offers our Legislative Watch to help keep you up-to-date on related legislation.
In this webinar, […]
MediSpend’s Chief Commercial Officer, Seth Houston, walks through the top six transparency reporting challenges and provides solutions to overcome those challenges.
On November 6, 2023, the U.S. Department of Health and Human Services (HHS) Office of Inspector General (OIG), in connection with the November 2023 Health Care Compliance Association’s (HCCA) Healthcare Enforcement Compliance Conference, published the General Compliance Program Guidance (GCPG) as a revised reference guide for the healthcare compliance community and other healthcare stakeholders.
During the […]
